Brain tissue-derived extracellular vesicles in Alzheimer’s disease display altered key protein levels including cell type-specific markers

Manuscript Number: 

22-0322R2

Author(s): 
Tanina Arab, Lesley Cheng, Tom A.P. Driedonks, Andrew F. Hill, Yiyao Huang, Vasiliki Mahairaki, Rajini Nagaraj, Olga Pletnikova, Bonita H. Powell, Harinda Rajapaksha, Javier Redding, David A. Routenberg, Juan C. Troncoso, Kenneth W. Witwer, Lei Zhang

Disclosures

Tanina Arab

  • Nothing to Disclose

Lesley Cheng

  • Nothing to Disclose

Tom A.P. Driedonks

  • Nothing to Disclose

Andrew F. Hill

  • Equity:
    Founding shareholder in D-Gen Ltd (UK) - an academic spinoff company established to develop diagnostics for neurodegenerative diseases. Shareholder since 2002.
    Patents/Royalties
    Patent AU2018904605 (Novel Methods) licenced to Jiangsu Beigeer Biomedical Co. Ltd (China) in April, 2018. Royalties received to date ~$US50,000

Yiyao Huang

  • Nothing to Disclose

Vasiliki Mahairaki

  • Nothing to Disclose

Rajini Nagaraj

  • Nothing to Disclose

Olga Pletnikova

  • Nothing to Disclose

Bonita H. Powell

  • Nothing to Disclose

Harinda Rajapaksha

  • Nothing to Disclose

Javier Redding

  • Nothing to Disclose

David A. Routenberg

  • Nothing to Disclose

Juan C. Troncoso

  • Equity:
    Snowflake $5000

Kenneth W. Witwer

  • Consulting Fees:
    I consult privately at an hourly rate and have received stock options for serving on an advisory board (see below).
    Equity:
    I have received stock options from NeuroDex, Inc., serving on their advisory board.
    Grants
    • Agency: 
      Yuvan Research, Inc.
      Dates: 
      February, 2022-present
    • Agency: 
      Ionis Pharmaceuticals
      Dates: 
      June, 2022-present

Lei Zhang

  • Nothing to Disclose